| Financial Year |
March 31 2023 |
| Monetary Funds |
836,103,402.62 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
236,914,718.68 |
| Advances to Suppliers |
170,257,417.96 |
| Other Receivables |
629,495,523.80 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,692,462,175.64 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
66,230,393.81 |
| Total Current Assets |
3,631,463,632.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
134,758,230.60 |
| Long-term Equity Investment |
246,909,824.53 |
| Investment Properties |
-- |
| Fixed Assetes |
10,469,949,026.96 |
| Under-construction Projects |
4,081,434,163.12 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
693,156,561.63 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
327,271,362.67 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
181,494,779.96 |
| Deferred Income Tax Assets |
8,786,506.63 |
| Other Non-Current Assets |
104,328,738.64 |
| Sub-Total of Non-Current Assets |
18,561,886,617.38 |
| Total Assets |
22,193,350,249.89 |
| Short-Term Loans |
12,661,913,242.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,304,116,348.51 |
| Accounts Payable |
3,689,721,735.59 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
71,765,136.31 |
| Taxes Payable |
111,975,157.14 |
| Interest Payable |
662,692,771.36 |
| Dividend Payable |
2,415,311.46 |
| Other payables |
3,877,795,150.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,335,002,184.95 |
| Other Current Liabilities |
471,730,000.00 |
| Sub-Total of Current Liabilities |
27,640,519,871.13 |
| Long-term Loans |
2,138,483,405.72 |
| Bonds Payable |
1,650,404,407.63 |
| Long-Term Accounts Payable |
301,489,860.25 |
| Special Payable |
-- |
| Estimatied Liabilities |
28,923,496.39 |
| Deferred Income Tax Liabilities |
612,178.89 |
| Other Non-Current Liabilities |
1,085,884,725.14 |
| Sub-Total of Non-Current Liabilities |
7,200,135,898.15 |
| Total Liabilities |
34,840,655,769.28 |
| Paid-In Capital(Or Share Stock) |
3,138,569,154.00 |
| Capital Surplus |
13,740,713,178.51 |
| Surplus Reserve |
620,331,902.51 |
| LESS:Treasury Stock |
495,412,501.16 |
| Undistributed Profits |
-27,060,169,660.85 |
| Minority Stockholder's Interest |
-2,725,855,985.52 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-9,921,449,533.87 |
| Owner's Equity（Stockholder's Equity） |
-12,647,305,519.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
22,193,350,249.89 |
